| __timestamp | Bristol-Myers Squibb Company | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5699000000 | 19928000 |
| Thursday, January 1, 2015 | 5001000000 | 30842000 |
| Friday, January 1, 2016 | 5002000000 | 46527000 |
| Sunday, January 1, 2017 | 4849000000 | 34451000 |
| Monday, January 1, 2018 | 4551000000 | 34409000 |
| Tuesday, January 1, 2019 | 4871000000 | 34417000 |
| Wednesday, January 1, 2020 | 7661000000 | 145290000 |
| Friday, January 1, 2021 | 7690000000 | 298358000 |
| Saturday, January 1, 2022 | 7814000000 | 488691000 |
| Sunday, January 1, 2023 | 7772000000 | 468946000 |
| Monday, January 1, 2024 | 8414000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Bristol-Myers Squibb Company and Novavax, Inc. from 2014 to 2023. Over this period, Bristol-Myers Squibb consistently outspent Novavax, with its SG&A expenses peaking in 2022 at approximately 7.8 billion dollars, a 70% increase from 2014. In contrast, Novavax's expenses, while significantly lower, showed a dramatic rise, especially post-2020, reaching nearly 490 million dollars in 2022, marking a staggering 2,350% increase from 2014. This surge reflects Novavax's aggressive market expansion and strategic investments in response to global health challenges. As the pharmaceutical landscape continues to shift, these financial trends offer a window into the strategic priorities and market positioning of these industry giants.
Operational Costs Compared: SG&A Analysis of Novo Nordisk A/S and Novavax, Inc.
Bristol-Myers Squibb Company or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Neurocrine Biosciences, Inc.
Bristol-Myers Squibb Company or Catalent, Inc.: Who Manages SG&A Costs Better?
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company vs Evotec SE: SG&A Expense Trends
Gilead Sciences, Inc. vs Novavax, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Grifols, S.A. or Novavax, Inc.
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.